Effects of oral administration of L-arginine on renal function in patients with heart failure

Journal of Hypertension

Volumn 18, Issue 2, 2000, Pages 229-234

  Watanabe, Gohki ^a   Tomiyama, Hirofumi ^a   Doba, Nobutaka ^a  

^a TEIKYO UNIVERSITY CHIBA MEDICAL CENTER   (Japan)

Author keywords

Endothelin; Heart failure; L arginine; Nitric oxide; Renal function; Sodium balance

Indexed keywords

ARGININE; CREATININE; CYCLIC GMP; ENDOTHELIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; GLOMERULUS FILTRATION RATE; HORMONE BLOOD LEVEL; HUMAN; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; MALE; NATRIURESIS; PRIORITY JOURNAL; SALT LOADING; SODIUM URINE LEVEL;

EID: 0033996620     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200018020-00015     Document Type: Article

References (31)

1. 1 Cody RJ. Sodium and water retention in congestive heart failure - the pivotal role of kidney. Am J Hypertens 1988; 1:395S-401S.
2. 2 Cleland JGF, Dargie HJ. Heart failure, renal function, and angiotensin converting enzyme inhibitors. Kidney Int 1987; 31:220S-228S.
3. 3 Awazu M, Ichikawa I. Alterations in renal function in experimental congestive heart failure. Semin Nephrol 1994; 14:401-411.
4. 4 Remme W. Therapeutic strategies and neurohormonal control in heart failure. Eur Heart J 1994; 15:129D-138D.
5. 5 Elsner D. Changes in neurohormonal systems during the development of congestive heart failure: impact of cardiovascular and renal function. Eur Heart J 1995; 16:52N-58N.
6. 6 Bachmann S, Mundel P. Nitric oxide in the kidney: synthesis, localization, and function. Am J Kid Dis 1994; 24:112-129.
7. 7 Remuzzi AS, Noris M. Nitric oxide/endothelin balance after nephron reduction. Kidney Int 1998; 65:S63-S67.
8. 8 Drexler H. Endothelial dysfunction: clinical implications. Prog Cardiovasc Dis 1997; 39:287-324.
9. 9 Drexler H, Hornig B. Importance of endothelial function in chronic heart failure. J Cardiovasc Pharmacol 1996; 27:9S-12S.
10. 10 Koifman B, Wollman Y, Bogomolny N, Chernichowsky T, Finkelstein A, Peer G, et al. Improvement of cardiac performance by intravenous infusion of L-arginine in patients with moderate congestive heart failure. J Am Coll Cardiol 1995; 26:1251-1256.
11. 11 Rector TR, Bank AJ, Mullen KA, Tschumperlin LK, Sih R, Pillai K, et al. Randomized, double-blind, placebo-controlled study of supplemental oral L-arginine in patients with heart failure. Circulation 1996; 93:2135-2141.
12. 12 Tomiyama H, Nishikawa E, Watanabe G, Shiojoma K, Shimada K, Yamamoto A, et al. Hormonal and cardiorenal responses to acute saline loading in mild congestive heart failure - effects of angiotensin converting enzyme inhibition. Jpn Circ J 1998; 62:29-35.
13. 13 Moulinier LM, Venet T, Schiller NB, Kurt TW, Morris RC, Sebastian A. Measurement of aortic blood flow by Doppler echocardiograpny: day to day variability in normal subjects and applicability in clinical research. J Am Coll Cardiol 1991; 17:1326-1333.
14. 15N] nitrate in biological fluids. Anal Biochem 1982; 126:131-138.
15. 15 Grandes S, Gallaego MJ, Riesco A, Lopez-Farre A, Casado S, Hernando L, et al. Mechanisms of renal effects of different agents stimulating production of cGMP. Am J Physiol 1991; 261:H1109-H1114.
16. 16 Pomerleau J, Verde M, Garble DR, Nude MH. Effects of protein intake on glycaemic control and renal function in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1993; 36:829-835.
17. 17 Boulanger CM, Luscher TF. Release of endothelin from the procine aorta: inhibition by endothelium derived nitric oxide. J Clin Invest 1990; 85:587-590.
18. 18 King AJ, BM Brenner, Anderson S. Endothelin: a potent renal and systemic vasoconstrictor peptide. Am J Physiol 1989; 256:F1051-F1058.
19. 19 Loutzenhiser R, Epstein M, Hayashi K, Horton C. Direct visualization of effects of endothelin on the renal microvasculature. Am J Physiol 1990; 258:F61-F68.
20. 20 Bijisma JA, Rabelink AJ, Kaasjager KAH, Koomans HA. L-arginine does not prevent the renal effects of endothelin in humans. J Am Soc Nephrol 1995; 5:1508-1516.
21. 21 Imig JD, Roman RJ. Nitric oxide modulates vascular tone in preglomerular arterioles. Hypertension 1992; 19:770-774.
22. 22 Ito S, Arima S, Ren YL, Juncos LA, Carretero OA. Endothelium-derived relaxing factor/nitric oxide modulates angiotensin II action in the isolated microperfused rabbit afferent arteriole but not efferent arteriole. J Clin Invest 1993;91:2012-2019.
23. 23 Nussberger J, Fleck E, Bahrmann H, Delius W, Schultheissll HP, Brunner HR. Dose-related effects of ACE inhibition in man: quinapril in patients with moderate congestive heart failure. Eur Heart J 1994; 15:113D-122D.
24. 24 Ito S, Ren YL. Evidence for the role of nitric oxide in macula densa control of glomerular hemodynamics. J Clin Invest 1993; 92:1093-1098.
25. 25 Majid DSA, Williams A, Navar LG. Inhibition of nitric oxide synthesis attenuates pressure-induced natriuretic responses in anesthetized dogs. Am J Physiol 1993; 233:F79-F87.
26. 26 Haynes WG, Hand MF, Dockrell MEC, Eadington DW, Lee MR, Hussein Z, et al. Physiological role of nitric oxide in regulation of renal function in humans. Am J Physiol 1997; 272:F364-F371.
27. 27 Weiberg MS. Renal effects of angiotensin converting enzyme inhibitors in heart failure: a clinician's guide to minimizing azotemia and diuretic-induced electrolyte imbalances. Clin Therap 1993; 15:3-17.
28. 28 Tsutamoto T, Wada A, Maeda K, Nakamura M, Kinoshita M. Prognostic value of plasma intercellular adhesion molecule-1 and endothelin-1 concentration in patients with chronic congestive heart failure. Am J Cardiol 1995; 76:803-808.
29. 29 DeSanto NG, Cirillo M, Anastasio P, Spitali L, Capasso G. Renal response to an acute oral protein load in healthy humans and in patients with renal disease or liver cirrhosis. Semin Nephrol 1995; 15:426-432.
30. 30 Magri P, Rao MAE, Cangianiello S, Bellizzi V, Russo R, Mele AF, et al. Early impairment of renal hemodynamic reserve in patients with asymptomatic heart failure is restored by angiotensin II antagonism. Circulation 1998; 98:2849-2854.
31. 31 Juncos L, Cornejo JC, Pamies-Andreu E, Romero JC. Renal response to amino acid infusion in essential hypertension. Hypertension 1994, 23 (suppl I):I225-I230.